Nephrologist Patrik Finne has warned that common over-the-counter anti-inflammatory drugs can pose risks to kidney health, especially for elderly individuals and those suffering from other diseases. The long-term use of such medications raises particular concerns about kidney damage, underlining the importance of careful consideration before using these widely available drugs. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, ketoprofen, and diclofenac—available under brands like Burana and Voltaren—are highlighted as medication categories that could potentially exacerbate kidney issues.

Finne emphasizes the significance of following dosage guidelines for safer alternatives to pain relief. Among these, acetaminophen is indicated as the safest option for kidney health when dosage recommendations are strictly adhered to. This caution serves not only as advice for patients but also raises awareness around responsible pain management, particularly for those with pre-existing health complications.

The findings remind medical professionals and patients alike to assess the benefits and risks associated with the use of common pain relievers. As a preventive measure, monitoring the long-term effects of these medications could lead to better health outcomes and reduce the incidence of medication-related kidney damage, which is often overlooked in patient care.